Meg Fitzgerald

Ms. Fitzgerald brings over twenty years of experience across the biotechnology industry. Most recently, she served as Senior Vice President, General Counsel, Corporate Secretary, and Chief Compliance Officer at Allakos Inc., where she provided strategic legal advice on securities, litigation, IP strategy, clinical development, and commercialization. Prior to Allakos, Ms. Fitzgerald was Associate General Counsel and Privacy Officer at Aimmune Therapeutics, Inc. Previously, she served as Vice President of Corporate Law at ZS Pharma, Inc., where she chaired negotiations, resulting in the $2.7 billion sale of ZS Pharma to AstraZeneca. Earlier in her career, Ms. Fitzgerald held increasingly senior leadership roles at Genentech, Inc., ultimately serving as Associate General Counsel and Director of Transactional Law. Ms. Fitzgerald also served as an Associate Attorney at Pillsbury Winthrop Shaw Pittman. She holds a J.D. from the University of California, Berkeley, as well as both an M.A. and B.A. in History from Stanford University.